PetMed Express Inc. (PETS)
undefined
undefined%
At close: undefined
5.51
0.00%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.

The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.

It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

The company also sells food, beds, crates, stairs, and other pet supplies.

It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands.

PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express Inc.
PetMed Express Inc. logo
Country United States
IPO Date Apr 26, 1999
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 287
CEO Sandra Y. Campos

Contact Details

Address:
420 South Congress Avenue
Delray Beach, Florida
United States
Website https://www.1800petmeds.com

Stock Details

Ticker Symbol PETS
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001040130
CUSIP Number 716382106
ISIN Number US7163821066
Employer ID 65-0680967
SIC Code 5912

Key Executives

Name Position
Sandra Y. Campos President, Chief Executive Officer & Director
Carla Dodds Chief Marketing Officer
Caroline Conegliano Chief Operating Officer
Robyn DElia Chief Financial Officer
Christine Chambers Treasurer & Secretary
Doug Krulik Chief Accounting Officer
Jacqueline Smith Vice President of People
Mark Moseley Chief Technology & Information Officer
Umesh Sripad Chief Digital & Technology Officer
Wendy Zalai Corporate Controller & Corporate Secretary

Latest SEC Filings

Date Type Title
Dec 10, 2024 4 Filing
Dec 06, 2024 4 Filing
Dec 03, 2024 8-K Current Report
Dec 03, 2024 8-A12B Filing
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 07, 2024 10-Q Quarterly Report
Nov 06, 2024 8-K Current Report
Oct 18, 2024 4 Filing
Oct 18, 2024 3 Filing
Oct 10, 2024 SC 13G Statement of acquisition of beneficial ownership b...